Company GreenLight Biosciences Holdings
Equities
GRNA
US39536G1058
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 23-07-23 |
Drew Cunningham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Amin Khan
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Nina Thayer
CMP | Compliance Officer | - | 23-02-28 |
Carole Cobb
COO | Chief Operating Officer | 66 | - |
Thomas Crampton
PRN | Corporate Officer/Principal | - | - |
Mark Singleton
PRN | Corporate Officer/Principal | 56 | - |
Charu Manocha
HRO | Human Resources Officer | 57 | 19-12-31 |
Corporate Officer/Principal | 51 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrey Zarur
CEO | Chief Executive Officer | 54 | - |
Clay Mitchell
PSD | President | - | 23-07-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 151,681,314 | 119,177,217 ( 78.57 %) | 0 | 78.57 % |
Company contact information
GreenLight Biosciences Holdings PBC
29 Hartwell Avenue
02421, Lexington
+
http://www.greenlightbiosciences.comSector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |